Journal article
Renal denervation in combination with angiotensin receptor blockade prolongs blood pressure trough during hemorrhage
RR Singh, Z McArdle, LC Booth, CN May, GA Head, KM Moritz, MP Schlaich, KM Denton
Hypertension | Published : 2022
Abstract
Majority of patients with hypertension and chronic kidney disease (CKD) undergoing renal denervation (RDN) are maintained on antihypertensive medication. However, RDN may impair compensatory responses to hypotension induced by blood loss. Therefore, continuation of antihypertensive medications in denervated patients may exacerbate hypotensive episodes. This study examined whether antihypertensive medication compromised hemodynamic responses to blood loss in normotensive (control) sheep and in sheep with hypertensive CKD at 30 months after RDN (control-RDN, CKD-RDN) or sham (control-intact, CKD-intact) procedure. CKD-RDN sheep had lower basal blood pressure (BP; ≈9 mm Hg) and higher basal ren..
View full abstractRelated Projects (1)
Grants
Funding Acknowledgements
This research was supported by a project grant (no. 1046594) and fellowships to K.M. Denton (no. 1041844), K.M. Moritz (no. 1078164), M.P. Schlaich (no. 1080404), and L.C. Booth (no. 1054619) from the National Health and Medical Research Council of Australia.